Bedel Financial Consulting’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-154
| Closed | -$7K | – | 986 |
|
|
2021
Q4 | $7K | Hold |
154
| – | – | ﹤0.01% | 725 |
|
|
2021
Q3 | $8K | Hold |
154
| – | – | ﹤0.01% | 701 |
|
|
2021
Q2 | $12K | Hold |
154
| – | – | ﹤0.01% | 634 |
|
|
2021
Q1 | $9K | Hold |
154
| – | – | ﹤0.01% | 654 |
|
|
2020
Q4 | $13K | Hold |
154
| – | – | 0.01% | 511 |
|
|
2020
Q3 | $6K | Hold |
154
| – | – | ﹤0.01% | 586 |
|
|
2020
Q2 | $4K | Hold |
154
| – | – | ﹤0.01% | 610 |
|
|
2020
Q1 | $3K | Hold |
154
| – | – | ﹤0.01% | 627 |
|
|
2019
Q4 | $3K | Hold |
154
| – | – | ﹤0.01% | 631 |
|
|
2019
Q3 | $2K | Buy |
+154
| New | +$2K | ﹤0.01% | 648 |
|